-
IIT, BHU to re-purpose approved drugs from DrugBank database for treating COVID-19
expresspharma
June 04, 2020
The research group is working on developing new drug candidates against SARS-CoV-2 by exploring DrugBank database compounds as an inhibitor of SARS-CoV-2 main protease, a key enzyme required for SARS-CoV-2 assembly and multiplication.
-
Genentech gets FDA approval for Tecentriq, Avastin combo for HCC
pharmaceutical-business-review
June 03, 2020
Genentech has secured approval from the US Food and Drug Administration (FDA) for Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) for the treatment of unresectable or metastatic hepatocellular carcinoma (HCC).
-
FDA approves new indication for AstraZeneca’s heart disease drug Brilinta
pharmaceutical-business-review
June 03, 2020
AstraZeneca has secured approval from the US Food and Drug Administration (FDA) for its Brilinta (ticagrelor) to minimise the risk of a first heart attack or stroke in high-risk patients with a heart disease known as coronary artery disease (CAD).
-
Moleculin Provides Update on Coronavirus Drug Development
americanpharmaceuticalreview
June 03, 2020
Moleculin Biotech announced the US Food and Drug Administration (FDA) has granted the Company's request for a Pre-IND Meeting to provide guidance regarding the Company's plan to study its drug candidate, WP1122 ...
-
FDA Approves Nivolumab plus Ipilimumab, Chemotherapy for Metastatic NSCLC
americanpharmaceuticalreview
June 03, 2020
The Food and Drug Administration (FDA) approved the combination of nivolumab (OPDIVO, Bristol-Myers Squibb) plus ipilimumab (YERVOY, Bristol-Myers Squibb) ...
-
FDA Approves Treatment for Bladder Dysfunction in Pediatric Patients
americanpharmaceuticalreview
June 03, 2020
The U.S. Food and Drug Administration (FDA) granted approval to VESIcare LS (solifenacin succinate) oral suspension.
-
Strides receives USFDA approval for Triamcinolone Acetonide Ointment
expresspharma
June 03, 2020
Product approval from flagship facility in Bangalore, to be marketed by Strides Pharma in the US.
-
India’s only certified TB Bacteria and H1N1 Virus disinfectant formulation now hits the retail marke
expresspharma
June 03, 2020
Tranquiil Specialty Products announced that its range of India’s first and only certified disinfectant formulations which are H1N1 Virus and Tuberculosis Bacteria resistant have now hit the retail market.
-
Lupin receives US FDA approval for Meloxicam capsules
expresspharma
June 03, 2020
Lupin's Meloxicam capsules are a generic equivalent of Vivlodex Capsules of Zyla Life Sciences US.
-
FDA Approves Brigatinib for ALK-Positive Metastatic NSCLC
americanpharmaceuticalreview
June 02, 2020
The Food and Drug Administration (FDA) approved brigatinib (ALUNBRIG, ARIAD) for adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.